Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
It is typically administered via a weekly injection, which helps regulate insulin secretion, slows gastric emptying, and reduces food intake
Your physician will recommend the best fit based on your labs, history, and goals
(1) This medication is a subcutaneous injection, which means it is injected beneath the skin
Continuing semaglutide as prescribed ensures you maintain steady metabolic progress underneath these temporary hormonal shifts
Our ongoing 12-week study in Australia is well positioned to further evaluate the effectiveness of DehydraTECH over an extended dosing duration and potentially establish Lexaria as a global player in oral delivery within the fast-growing GLP-1 weight loss and diabetes control markets." All the results of this study - reduced side effects, comparable end of Study blood sugar control and measured drug in bloodstream - are extremely encouraging and support our decision to further evaluate DehydraTECH-tirzepatide in our ongoing Australian Phase 1b registrational study (GLP-1-H24-4)
US$ 24.63
US$ 28.94
US$ 28.99
US$ 27.81
